LOPREEZA Trademark

Trademark Overview

On Thursday, June 26, 2014, a trademark application was filed for LOPREEZA with the United States Patent and Trademark Office. The USPTO has given the LOPREEZA trademark a serial number of 86321948. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, August 29, 2025. This trademark is owned by Amneal Pharmaceuticals LLC. The LOPREEZA trademark is filed in the Pharmaceutical Products category with the following description:

Hormone preparations for hormone replacement therapy for treatment of women in menopause
lopreeza

General Information

Serial Number86321948
Word MarkLOPREEZA
Filing DateThursday, June 26, 2014
Status710 - CANCELLED - SECTION 8
Status DateFriday, August 29, 2025
Registration Number4690032
Registration DateTuesday, February 17, 2015
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, October 7, 2014

Trademark Statements

Goods and ServicesHormone preparations for hormone replacement therapy for treatment of women in menopause

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, August 29, 2025
Primary Code005
First Use Anywhere DateThursday, November 20, 2014
First Use In Commerce DateThursday, November 20, 2014

Trademark Owner History

Party NameAmneal Pharmaceuticals LLC
Party Type30 - Original Registrant
Legal Entity Type16 - Limited Liability Company
AddressBridgewater, NJ 08807
Party NameAmneal Pharmaceuticals LLC
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressBridgewater, NJ 08807
Party NameAmneal Pharmaceuticals LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressBridgewater, NJ 08807

Trademark Events

Event DateEvent Description
Friday, August 29, 2014APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, December 2, 2014TEAS STATEMENT OF USE RECEIVED
Tuesday, December 2, 2014NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, December 2, 2014USE AMENDMENT FILED
Monday, June 30, 2014NEW APPLICATION ENTERED
Thursday, July 3, 2014NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, August 28, 2014ASSIGNED TO EXAMINER
Wednesday, September 17, 2014NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, October 7, 2014PUBLISHED FOR OPPOSITION
Tuesday, October 7, 2014OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Monday, January 12, 2015CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, January 13, 2015STATEMENT OF USE PROCESSING COMPLETE
Wednesday, January 14, 2015ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Thursday, January 15, 2015NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Tuesday, February 17, 2015REGISTERED-PRINCIPAL REGISTER
Monday, February 17, 2020COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Tuesday, December 1, 2020TEAS SECTION 8 & 15 RECEIVED
Wednesday, November 25, 2015ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Wednesday, July 4, 2018ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Wednesday, July 18, 2018ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Friday, March 5, 2021NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Friday, August 29, 2025CANCELLED SEC. 8 (10-YR)/EXPIRED SECTION 9
Tuesday, September 2, 2025ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Friday, March 5, 2021CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Friday, March 5, 2021REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Wednesday, June 1, 2022ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Saturday, February 17, 2024COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Wednesday, January 29, 2025ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY

Related Keywords

lopreeza hormone women menopause treatment therapy preparations replacement